These studies demonstrated that normal tissue usually express low levels of this kinase as compared to those found in tumor samples (42, , –45) and that overexpression of S6K2 was more common than that of S6K1 (e.g., 80 versus 25% in breast and 18 versus 8% for endometrial cancer). Here, RPS6KB2 is linked to endometrial cancer.